Stay updated on Novel CAR-T Cells for Hematological Malignancy Clinical Trial
Sign up to get notified when there's something new on the Novel CAR-T Cells for Hematological Malignancy Clinical Trial page.

Latest updates to the Novel CAR-T Cells for Hematological Malignancy Clinical Trial page
- Check6 days agoChange DetectedThe study record history now shows Revision: v3.6.5, replacing the previous v3.6.4. This indicates an administrative update to the record in the history log.SummaryDifference0.1%

- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedThe record history shows the site updated from version v3.6.3 to v3.6.4, indicating a system upgrade. This does not modify the study details or visible content on the page.SummaryDifference0.1%

- Check27 days agoNo Change Detected
- Check42 days agoChange DetectedAn updated Revision tag to v3.6.3 is now shown on the page, replacing the previous v3.6.2. This represents a minor release update to the site metadata and does not alter study data or page functionality.SummaryDifference0.1%

- Check49 days agoChange DetectedA new revision version v3.6.2 appears in the record history, replacing the previous v3.6.0, indicating an updated iteration of the study record history page.SummaryDifference0.1%

- Check63 days agoChange DetectedNew provenance fields 'Last verified' and 'Last known status was' were added to the study record history, and the revision label updated to v3.6.0. These changes clarify when a version was last checked and its status, enhancing version-tracking context.SummaryDifference3%

- Check70 days agoChange DetectedA new revision entry v3.5.5 was added to the study's record history and the previous revision v3.5.4 was removed, indicating an administrative update to the record.SummaryDifference0.1%

Stay in the know with updates to Novel CAR-T Cells for Hematological Malignancy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Novel CAR-T Cells for Hematological Malignancy Clinical Trial page.